Key facts
- This page summarizes Everett Cunningham's Form 4 filing for EXACT SCIENCES CORP (EXAS).
- 4 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 28 Feb 2024, 19:37.
Everett Cunningham - 26 Feb 2024 Form 4 Insider Report for EXACT SCIENCES CORP (EXAS)
- Reporting relationship
- Chief Commercial Officer
- Issuer ticker
- EXAS
- Reported as of
- 26 Feb 2024
- Net transaction value
- -$207,535
- SEC form
- 4
- Accepted by SEC
- 28 Feb 2024, 19:37:36 UTC
- Prior SEC filing
- 23 Feb 2024
- Next SEC filing
- 04 Mar 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Everett Cunningham by Mark R. Busch, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Everett Cunningham filed Form 4 for EXACT SCIENCES CORP (EXAS) on 28 Feb 2024.
Change
- Previous filing in this sequence was filed on 23 Feb 2024.
- Current net transaction value: -$207,535.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
EXAS
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +7,678
- Change %
- +20%
- Price
- $0.000000
- Shares after
- 46,948
- Date
- 26 Feb 2024
- Ownership
- Direct
- Footnotes
- F1
EXAS
transaction
Common Stock
Sale
- Transaction value
- $207,535
- Shares
- -3,648
- Change %
- -7.8%
- Price
- $56.89
- Shares after
- 43,300
- Date
- 27 Feb 2024
- Ownership
- Direct
- Footnotes
- F2, F3
EXAS
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 571
- Date
- 26 Feb 2024
- Ownership
- Held in 401(k) Plan
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
EXAS
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -7,678
- Change %
- -33%
- Price
- $0.000000
- Shares after
- 15,356
- Date
- 26 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 7,678
- Exercise price
- Footnotes
- F4, F5
EXAS
transaction
Derivative
Restricted Stock Units
Award
- Transaction value
- $0
- Shares
- +31,668
- Change %
- Price
- $0.000000
- Shares after
- 31,668
- Date
- 26 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 31,668
- Exercise price
- Footnotes
- F4, F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 6 footnotes
Footnote F1
Represents shares of common stock received upon vesting of a restricted stock unit award.
Footnote F2
Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain restricted stock units.
Footnote F3
In addition to the shares of Common Stock reported on this Form 4, which total 43,871 shares, Mr. Cunningham also holds, in the aggregate, an additional 95,697 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.
Footnote F4
Each restricted stock unit represents a contingent right to receive one share of common stock.
Footnote F5
Represents a restricted stock unit award that partially vested on February 26, 2024. The restricted stock units vest in four equal annual installments from the grant date.
Footnote F6
These restricted stock units vest in four equal annual installments beginning on February 28, 2025.